GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medivolve Inc (OTCPK:MEDVF) » Definitions » Research & Development

Medivolve (Medivolve) Research & Development : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Medivolve Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medivolve's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Medivolve Research & Development Historical Data

The historical data trend for Medivolve's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivolve Research & Development Chart

Medivolve Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medivolve Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medivolve Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medivolve  (OTCPK:MEDVF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medivolve Research & Development Related Terms

Thank you for viewing the detailed overview of Medivolve's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Medivolve (Medivolve) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medivolve Inc (OTCPK:MEDVF) » Definitions » Research & Development
Comparable Companies
TSXV:MBI.H XCNQ:VTAL TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT XPAR:BIM EXAS RVTY XPAR:ERF ASX:SHL
Traded in Other Exchanges
4NCA:Germany MEDV:Canada
Address
198 Davenport Road, Toronto, ON, CAN, M5R 1J2
Website
https://www.medivolve.ca
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.